ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

BSA Working Group

November 12, 2010

In Brief: ACS Massachusetts Div. Offers $1,500 Grants To Improve community Hospital Cancer Care

March 2, 1979

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System

December 15, 1989